GLP-1/GIP/Glucagon Triple Agonist
10 mg
Body Protection Compound-157
10 mg
Copper Tripeptide-1
50 mg
B-Nicotinamide Adenine Dinucleotide
500 mg
Elamipretide (Bendavia)
10 mg
Mitochondrial-Derived Peptide
10 mg
CJC-1295 with Drug Affinity Complex
10 mg
Semax Heptapeptide
10 mg
Epitalon Tetrapeptide
50 mg
Evidence-led research guides on the compounds we ship — mechanism, common research dosing ranges, reconstitution math, and how peptides layer.
metabolic
Retatrutide is a single-molecule triple agonist of GLP-1, GIP, and glucagon receptors. In published trials it produced larger metabolic and body-composition shifts than dual-agonist or single-agonist research peptides over the same study window. Common research dose ranges run 1–6 mg weekly, typically titrated up.
wellness
GHK-Cu is the copper-bound form of the tripeptide Glycyl-L-Histidyl-L-Lysine. It modulates over 4,000 genes related to tissue remodelling, fibroblast activity, and anti-inflammatory pathways. Common research doses run 1–3 mg subcutaneously, 2–5 times per week.
wellness
BPC-157 (cytoprotection, angiogenesis, gut-vagal signalling) and TB-500 (actin sequestration, cell migration, immune modulation) hit complementary mechanisms. Research protocols commonly run BPC-157 at 250–500 mcg/day and TB-500 at 2–5 mg per week, often as a loading phase followed by maintenance.
Research-grade peptides synthesized to ≥98% HPLC verified purity.
Every batch verified for purity and identity by independent labs.
Cold-chain logistics to qualified researchers in 50+ countries.
Built for laboratories, researchers, and serious investigators.